Testing efficacy of Homoeopathic Medicine Camphora 1000 C as an immune booster, reducing the incidence of coronavirus infection.

Testing efficacy of Homoeopathic Medicine Camphora 1000 C as an immune booster, reducing the incidence of coronavirus infection- a double blind randomized, placebo controlled, clinical trial. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027688

Enrollment

3000

Registered

2020-09-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Camphora 1000 C: 4 pills Morning & Evening for 28 days. No Food or drink 15-20 minutes before or after taking. Control Intervention1: Placebo: 4 pills Morning & Evening for 28 days. No

Eligibility

Inclusion criteria

Inclusion criteria: Asymptomatic (w.r.t Covid-19 illness) subjects with community exposure from household or workplaces or high risk frontline workers etc. Above the age of 20 years till 60 years Both genders and transgender. All existing co morbidities with stable prescription. Individuals not detected with COVID 19 antibodies (Both IgG and IgM) at screening and negative with RT-PCR test as well

Exclusion criteria

Exclusion criteria: All COVID-19 positive RT- PCR cases (Symptomatic and asymptomatic). Individuals detected with any of the COVID 19 antibodies ie any of IgG and IgM at the time of screening COVID 19 cases with mild to moderate symptoms e.g. Fever, Cough-Dry or productive, Throat Pain, Nasal congestion, Coryza, Myalgia, Weakness, Headache, diarrhoea. Women who are Pregnant or Lactating. Age group below 20 years. Patients with pre-existing conditions: ESRD, HIV, Cancer of any organ or system on active chemo therapy or radiation. Cancer Survivor. Known Immune suppressed health status due use of oral steroids, immune-modulators as treatment for chronic co morbidities. Known cases of acute exacerbation of: IHD, COPD, Asthma. Those with end stage renal disease and progressive liver dysfunctions Anyone who has taken HCQS in previous one week or Homoeopathic prophylaxis Ars alb 30 in last 15 days or must not have used any other similar medicines for boosting the immunity against Covid-19 illness.

Design outcomes

Primary

Measure	Time frame
To compare the effectiveness of homoeopathic Medicine Camphora 1000 C as an immune booster in reducing incidence of COVID 19 infection by total Covid specific antibody testing.Timepoint: At Baseline and end of study ie day 42	—

Secondary

Measure	Time frame
To study the safety based on adverse eventsTimepoint: From baseline to end of study ie 42 days	—

Countries

India

Contacts

Public ContactDr Rajendra Shrimali

The Other Song International Academy of Advanced Homoeopathy

meghnashah@theothersong.com9769684610

Outcome results